EVEREST MEDICINES
Live / Applied — Statement of use — non-final action mailed (as of 24 Feb 2026)
What this means for you
Not registered yet, but its 22 Feb 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98977528
- Mark type
- Stylized text
- Filed
- 22 Feb 2024
- Published for opposition
- 17 Dec 2024
- Attorney of record
- Khanh T. Glatzel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, pharmaceutical preparations for treating diseases and conditions in the field of oncology/hematology, immunology, cardiology, renal, infectious diseases, acute care, internal medicines, central nervous system, ophthalmology, respiratory, metabolic, dermatology, gastrointestinal or women's health; pharmaceutical drugs, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for health care, namely, pharmaceutical preparations for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal; pharmaceutical preparations for oral, intravenous, topical, parenteral, rectal or sublingual use in connection with humans for treating and preventing diseases or conditions in the fields of oncology, immunology, renal, internal medicines, dermatology, gastrointestinal.
Owner
- Everest Medicines (Singapore) Pte. Ltd., Singapore, SG
- Everest Medicines (Singapore) Pte. Ltd., Singapore, SG
Prosecution history
- 24 Feb 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 24 Feb 2026 — NON-FINAL ACTION E-MAILED
- 24 Feb 2026 — SU - NON-FINAL ACTION - WRITTEN
- 24 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Aug 2025 — USE AMENDMENT FILED
- 24 Feb 2026 — DIVISIONAL PROCESSING COMPLETE
- 08 Aug 2025 — DIVISIONAL REQUEST RECEIVED
- 08 Aug 2025 — TEAS REQUEST TO DIVIDE RECEIVED
- 13 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Dec 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Dec 2024 — PUBLISHED FOR OPPOSITION
- 11 Dec 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED